WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
AHLA Health Care Transactions Conference
Speaking Engagements
Wednesday, April 15, 2026
8:00 - 9:15 AM CT

Nashville, TN

Add to calendarRegister for event

On April 15th Wilson Sonsini partner Andrea Linna will present on the panel “Representing the Founders, Investors, and Innovators of Healthcare AI: Venture Capital and Emerging Companies.” The session will explore the central role venture capital plays in bringing healthcare AI to market and the complex legal landscape that founders and investors must navigate.

Key topics to be addressed during the panel include:

  • Navigating regulatory complexity. The panel will examine the legal and regulatory challenges that make healthcare AI especially complex, including data rights and access, patient harm liability considerations, and multilayered federal and state oversight, including through emerging healthcare AI-specific laws, corporate practice of medicine restrictions, and fraud and abuse considerations.
  • Effective counseling of startups and their investors in healthcare AI. Panelists will share insights on advising healthcare AI companies through formation, fundraising strategies, growth planning, and positioning for eventual exit, as well as how to be effective venture capital investor counsel given the rapidly evolving market.
  • Right-sizing compliance by stage. Panelists will discuss how healthcare regulatory compliance expectations should be calibrated to a company’s maturity. For example, when a seed-stage company cannot reasonably be held to the same compliance infrastructure as a Series B or later-stage company, and what level of compliance readiness is realistic and advisable at each stage of growth. The discussion will also address the gap that often emerges when early-stage companies seek pilots or contracts with health systems or other sophisticated partners, whose compliance requirements may be significantly more robust than what the startup has built, and the investment that may be required to bridge that gap.

Wednesday, April 15, 2026 | 8:00 - 9:15 AM | Representing the Founders, Investors, and Inventors of Health Care AI: Venture Capital and Emerging Companies

Panelists

  • Fannie Chen, Chief Operating Officer, 25madison
  • Carrie Kibler, General Counsel, Yosemite Management
  • Andrea Linna, Partner, Wilson Sonsini

The health law industry continues to evolve, and as such, industry professionals must stay up to date on the legal and business issues to consider when structuring deals and transactions for their clients and institutions. In-house and outside counsel, compliance professionals, consultants, and private equity professionals and venture capitalists will gain key insights regarding business and legal issues in mergers, acquisitions, joint ventures, and other health care transactions.  Attendees of this conference will develop knowledge surrounding current developments, strategies, and deal forecasts and learn critical business considerations that must be addressed before, during, and after a transaction.

Contacts

Madelaine Holden

mholden@wsgr.com

Presenters

Andrea Linna
Partner

Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than a decade dedicated to healthcare law, Andrea exclusively represents digital health and healthcare IT clients, from emerging companies to established industry players, investors, and healthcare systems. Andrea guides her clients through the patchwork of federal and state laws that apply to digital health companies, addressing issues such as corporate practice of medicine, Stark Law compliance, Anti-Kickback Statute considerations, fee splitting, billing Medicare and Medicaid, contracting with commercial payors, value-based care arrangements, artificial intelligence, remote patient monitoring, online prescribing, scope of practice, and licensing requirements.

View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.